United States
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 14.93 T
|
Sept. 30, 2024 | USD 2.06 | 1.98% |
|
United States |
|
2 |
USD 29.63 B
|
Dec. 31, 2023 | USD 542.49 | -0.56% |
|
United States |
|
3 |
USD 22.93 B
|
Dec. 31, 2023 | USD 152.15 | -0.47% |
|
United States |
|
4 |
USD 21.32 B
|
Dec. 31, 2023 | USD 293.23 | -1.24% |
|
United States |
|
5 |
USD 19.65 B
|
Dec. 31, 2023 | USD 64.03 | -0.91% |
|
United States |
|
6 |
USD 12.82 B
|
Dec. 31, 2023 | USD 183.90 | 4.70% |
|
United States |
|
7 |
USD 12.69 B
|
Dec. 31, 2023 | USD 26.52 | -1.45% |
|
United States |
|
8 |
USD 12.28 B
|
Dec. 31, 2023 | USD 58.95 | -0.32% |
|
United States |
|
9 |
USD 11.46 B
|
Dec. 31, 2023 | USD 56.48 | -0.60% |
|
United States |
|
10 |
USD 11.22 B
|
Dec. 31, 2023 | USD 461.68 | 5.31% |
|
United States |
|
11 |
USD 10.94 B
|
Dec. 31, 2023 | USD 285.42 | 0.49% |
|
United States |
|
12 |
USD 10.84 B
|
Dec. 31, 2023 | USD 672.98 | -1.48% |
|
United States |
|
13 |
USD 9.87 B
|
Jan. 31, 2024 | USD 98.16 | -0.50% |
|
United States |
|
14 |
USD 9.11 B
|
Dec. 31, 2023 | USD 310.41 | -0.79% |
|
United States |
|
15 |
USD 8.60 B
|
Dec. 31, 2023 | USD 39.42 | -3.95% |
|
United States |
|
16 |
USD 8.08 B
|
Dec. 31, 2023 | USD 597.75 | -1.48% |
|
United States |
|
17 |
USD 7.28 B
|
Dec. 31, 2023 | USD 127.93 | -0.68% |
|
United States |
|
18 |
USD 7.26 B
|
Dec. 31, 2023 | USD 97.20 | 0.26% |
|
United States |
|
19 |
USD 7.09 B
|
Dec. 31, 2023 | USD 98.82 | -0.13% |
|
United States |
|
20 |
USD 6.53 B
|
Dec. 31, 2023 | USD 395.70 | -0.91% |
|
United States |
|
21 |
USD 5.86 B
|
Dec. 31, 2023 | USD 222.74 | -0.15% |
|
United States |
|
22 |
USD 5.22 B
|
Dec. 31, 2023 | USD 571.88 | -1.43% |
|
United States |
|
23 |
USD 5.13 B
|
June 30, 2024 | USD 123.66 | -3.59% |
|
United States |
|
24 |
USD 4.58 B
|
March 31, 2024 | USD 594.75 | -1.63% |
|
United States |
|
25 |
USD 3.66 B
|
Dec. 31, 2023 | USD 74.16 | 0.53% |
|
United States |
|
26 |
USD 3.19 B
|
Dec. 31, 2023 | USD 32.56 | -1.63% |
|
United States |
|
27 |
USD 3.13 B
|
Sept. 30, 2024 | USD 254.21 | -1.64% |
|
United States |
|
28 |
USD 3.11 B
|
Aug. 31, 2024 | USD 10.28 | -10.30% |
|
United States |
|
29 |
USD 3.10 B
|
Feb. 3, 2024 | USD 61.64 | 0.98% |
|
United States |
|
30 |
USD 3.05 B
|
Dec. 31, 2023 | USD 391.29 | 0.22% |
|
United States |
|
31 |
USD 2.99 B
|
Dec. 31, 2023 | USD 351.17 | -0.32% |
|
United States |
|
32 |
USD 2.93 B
|
Dec. 31, 2023 | USD 811.08 | -1.48% |
|
United States |
|
33 |
USD 2.72 B
|
Dec. 31, 2023 | USD 86.83 | -0.90% |
|
United States |
|
34 |
USD 2.63 B
|
Dec. 31, 2023 | USD 82.61 | -0.18% |
|
United States |
|
35 |
USD 2.49 B
|
Dec. 31, 2023 | USD 88.30 | -1.40% |
|
United States |
|
36 |
USD 2.44 B
|
Dec. 31, 2023 | USD 271.31 | -2.11% |
|
United States |
|
37 |
USD 2.33 B
|
Sept. 28, 2024 | USD 72.14 | -0.04% |
|
United States |
|
38 |
USD 2.33 B
|
Dec. 31, 2023 | USD 31.90 | -4.26% |
|
United States |
|
39 |
USD 2.30 B
|
Sept. 30, 2024 | USD 247.60 | -0.36% |
|
United States |
|
40 |
USD 1.89 B
|
Dec. 31, 2023 | USD 81.33 | -0.37% |
|
United States |
|
41 |
USD 1.85 B
|
Dec. 31, 2023 | USD 42.95 | -0.28% |
|
United States |
|
42 |
USD 1.68 B
|
Dec. 31, 2023 | USD 113.72 | -0.64% |
|
United States |
|
43 |
USD 1.64 B
|
Dec. 31, 2023 | USD 72.45 | -1.05% |
|
United States |
|
44 |
USD 1.61 B
|
Dec. 31, 2023 | USD 360.88 | 0.56% |
|
United States |
|
45 |
USD 1.60 B
|
Dec. 31, 2023 | USD 126.13 | -0.56% |
|
United States |
|
46 |
USD 1.52 B
|
Dec. 31, 2023 | USD 10.40 | 0.87% |
|
United States |
|
47 |
USD 1.50 B
|
Dec. 31, 2023 | USD 201.36 | -0.21% |
|
United States |
|
48 |
USD 1.33 B
|
Oct. 31, 2024 | USD 151.52 | 0.09% |
|
United States |
|
49 |
USD 1.31 B
|
Dec. 31, 2023 | USD 38.10 | 2.36% |
|
United States |
|
50 |
USD 1.26 B
|
Dec. 31, 2023 | USD 17.61 | -1.57% |
|
United States |
The Healthcare company in United States with the highest Cash and Short-Term Investments is Outlook Therapeutics, Inc. (NasdaqCM: OTLK) at USD 14.93 T.
The Healthcare company in United States with the lowest Cash and Short-Term Investments is Celularity Inc. (NasdaqCM: CELU) at USD 227.00 K.
The top 10 Healthcare companies in United States by Cash and Short-Term Investments are Outlook Therapeutics, Inc., UnitedHealth Group Incorporated, Johnson & Johnson, Humana Inc., Centene Corporation, AbbVie Inc., Pfizer Inc., Bristol-Myers Squibb Company, CVS Health Corporation and Vertex Pharmaceuticals Incorporated.
The bottom 10 Healthcare companies in United States by Cash and Short-Term Investments are Celularity Inc., InfuSystem Holdings, Inc., DLH Holdings Corp., Precision Optics Corporation, Inc., Pilulka Lékárny a.s., Nutriband Inc., AMCON Distributing Company, Cryo-Cell International, Inc., Precipio, Inc. and Vivos Therapeutics, Inc..